Effect of acupoint catgut embedding combined with antidiabetic drugs on glucagon-like peptide-l level in diabetic patients
Objective:To investigate the effect of acupoint catgut embedding combined with antidiabetic drugs on the level of glucagon-like peptide-1(GLP-1)in diabetic patients.Methods:74diabetic patients were randomly divided into three groups:antidiabetic drugs combined with acupoint catgut embedding group,acupoint catgut embedding group and antidiabetic drugs group,and the level of glucagon-like peptide-1(GLP-1)was observed.Results:The levels of glucagon-like peptide-1(GLP-1)in the antidiabetic drugs combined with acupoint catgut embedding group has a statistically significant difference before and after treatment(P＜0.05),and there were statistically significant differences between the antidiabetic drugs combined with acupoint catgut embedding group,acupoint catgut embedding group and antidiabetic drugs group after treatment(P＜0.05).By comparing the levels of GLP-1 in the three groups of diabetes patients before and after treatment,the treatment effect was evalua-ted.The effective rate of the antidiabetic drugs combined with acupoint catgut embedding group was 92.00％,the effective rate of the acupoint catgut embedding group was 66.67％,and the effective rate of the antidiabetic drugs group was 80.00％.The effec-tive rate of the antidiabetic drugs combined with acupoint catgut embedding group was higher than the acupoint catgut embedding group and the antidiabetic drugs group,with statistical significance(P＜0.05).Conclusion:Acupoint catgut embedding com-bined with antidiabetic drugs has significant clinical effect on diabetes.This may be achieved by regulating patients'levels of glu-cagon-like peptide-1(GLP-1).
国家科技期刊平台
NSTL
万方数据
